Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT04217512
Clinical Trial
Pantoprazole in Cisplatin Nephrotoxicity
Recruiting
Phase 3
View on ClinicalTrials.gov →
Summary
Pantoprazole in Cisplatin Nephrotoxicity
Trial Details
NCT Number
NCT04217512
Lead Sponsor
Sherief Abd-Elsalam
Conditions
Oncology
Enrollment
60 participants
Start Date
2019-05-01
Primary Completion
2030-12-01
(estimated)
Study Completion
2030-12-30
(estimated)
Updated on ClinicalTrials.gov
2020-01-03